Correction: Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.
[This corrects the article DOI: 10.3389/fonc.2025.1566598.].
APA
Jin M, Wang Y, et al. (2026). Correction: Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.. Frontiers in oncology, 16, 1821472. https://doi.org/10.3389/fonc.2026.1821472
MLA
Jin M, et al.. "Correction: Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.." Frontiers in oncology, vol. 16, 2026, pp. 1821472.
PMID
41930188
Abstract
[This corrects the article DOI: 10.3389/fonc.2025.1566598.].
같은 제1저자의 인용 많은 논문 (5)
- Synergistic induction of ferroptosis by paclitaxel and sunitinib is mediated through SLC7A11 in lung cancer.
- Injectable hyaluronic acid-based hydrogels with carbon dots and an iron complex for embolization.
- Comment on "Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan".
- Deciphering 14-3-3β-mediated phosphorylated alterations of cancer-related proteome in cisplatin resistance of gastric cancer.
- A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome.